NCT05952141 is a NA clinical trial of Clinic Outreach in Cervical Cancer, sponsored by Abramson Cancer Center at Penn Medicine.

Who is sponsoring NCT05952141?

NCT05952141 is sponsored by Abramson Cancer Center at Penn Medicine.

What drugs are being tested in NCT05952141?

Interventions in NCT05952141: Clinic Outreach, Enhanced Outreach, Low-Touch Strategy, High-Touch Strategy.

What condition does NCT05952141 study?

NCT05952141 studies Cervical Cancer.

Is NCT05952141 still recruiting?

NCT05952141 is currently recruiting now. Last updated 30 March 2026.

Last reviewed 2026-03-30 · How we verify

NCT05952141

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Strategies to Close the Gap From Cervical Cancer Diagnosis to Treatment in Botswana

Recruiting now NA Last updated 30 March 2026

What this trial tests

NA trial testing Clinic Outreach in Cervical Cancer in 610 participants. Currently enrolling.

Timeline

1 September 2023

Primary endpoint
31 December 2026

31 August 2027

Quick facts

Lead sponsor	Abramson Cancer Center at Penn Medicine
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	sequential
Masking	single
Primary purpose	health services research
Enrollment	610
Start date	1 September 2023
Primary completion	31 December 2026
Estimated completion	31 August 2027
Sites	3 locations across Botswana, United States

Drugs / interventions tested

Clinic Outreach
Enhanced Outreach
Low-Touch Strategy
High-Touch Strategy

Conditions studied

Cervical Cancer — all drugs for Cervical Cancer →

Sponsor

Abramson Cancer Center at Penn Medicine — full company profile →

Who can join

18 and older, female only, with Cervical Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Investigators will test the effectiveness of adaptive strategies on timely adoption of cervical cancer treatment in Botswana using a pragmatic trial design.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Thibang Diphatlha: a sequential multiple assignment randomized trial designed to increase timely adoption of cervical cancer treatment in Botswana.
Rendle KA, Ramogola-Masire D, Grover S, Thibang Diphatlha Collective. · · 2024 · cited 1× · PMID 39533437 · DOI 10.1186/s43058-024-00659-9

Verify or expand the search:

Other recruiting trials for Cervical Cancer

Currently open trials in the same condition.

NCT07276360 — Hypofractionated Radiotherapy for the Treatment of Locally Advanced Cervical Cancer in Uganda · Phase 2 · recruiting
NCT05570422 — A Study to Evaluate the Safety, Tolerability, Preliminary Efficacy of KRC-01 · Phase 1 · recruiting
NCT07225530 — Implementation of Screen, Treat, and Triage for Women Living With HIV in La Romana (iSTAR) · NA · recruiting
NCT07209917 — Secondary Cervical Cancer Prevention of Vulnerable Women With HPV and HIV Co-infection in India · NA · recruiting
NCT07256236 — SKB264 Plus QL1706 in Recurrent or Metastatic Cervical Cancer · Phase 2 · recruiting

Other Abramson Cancer Center at Penn Medicine trials

Trials by the same sponsor.

NCT07478848 — Radiation, Oral Vancomycin, and CAR-T for B-Cell Lymphomas · Phase 1 · not yet recruiting
NCT07059611 — Neoadjuvant Intra-tumoral RP2 and FLOT in Gastroesophageal Adenocarcinoma · Phase 2 · not yet recruiting
NCT07454499 — Engaging M-health for Symptom Monitoring and Health Promotion for Women on Endocrine Therapy for Breast Cancer (EmSHAPE) · NA · not yet recruiting
NCT07222241 — Comparing Numbing Techniques in Mohs Micrographic Surgery · NA · recruiting
NCT06837480 — Photobiomodulation in Head and Neck Cancer-Related Chronic Lymphedema · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05952141 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Abramson Cancer Center at Penn Medicine
Last refreshed: 30 March 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05952141.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing